US6048729A
(en)
*
|
1987-05-01 |
2000-04-11 |
Transkaryotic Therapies, Inc. |
In vivo protein production and delivery system for gene therapy
|
US5786216A
(en)
*
|
1987-11-17 |
1998-07-28 |
Cytotherapeutics, Inc. |
Inner-supported, biocompatible cell capsules
|
US5283187A
(en)
*
|
1987-11-17 |
1994-02-01 |
Brown University Research Foundation |
Cell culture-containing tubular capsule produced by co-extrusion
|
US5773286A
(en)
*
|
1987-11-17 |
1998-06-30 |
Cytotherapeutics, Inc. |
Inner supported biocompatible cell capsules
|
US5418154A
(en)
*
|
1987-11-17 |
1995-05-23 |
Brown University Research Foundation |
Method of preparing elongated seamless capsules containing biological material
|
US5158881A
(en)
*
|
1987-11-17 |
1992-10-27 |
Brown University Research Foundation |
Method and system for encapsulating cells in a tubular extrudate in separate cell compartments
|
US5871472A
(en)
*
|
1987-11-17 |
1999-02-16 |
Brown University Research Foundation |
Planting devices for the focal release of neuroinhibitory compounds
|
US5106627A
(en)
*
|
1987-11-17 |
1992-04-21 |
Brown University Research Foundation |
Neurological therapy devices
|
US5182111A
(en)
*
|
1987-11-17 |
1993-01-26 |
Boston University Research Foundation |
In vivo delivery of active factors by co-cultured cell implants
|
US5487739A
(en)
*
|
1987-11-17 |
1996-01-30 |
Brown University Research Foundation |
Implantable therapy systems and methods
|
DE68922497T2
(de)
*
|
1988-08-24 |
1995-09-14 |
Marvin J Slepian |
Endoluminale dichtung mit bisdegradierbaren polymeren.
|
US5011472A
(en)
*
|
1988-09-06 |
1991-04-30 |
Brown University Research Foundation |
Implantable delivery system for biological factors
|
CA2062746C
(en)
*
|
1989-06-21 |
1999-02-02 |
Patrick Aebischer |
Neurological therapy system
|
WO1991000119A1
(en)
*
|
1989-06-30 |
1991-01-10 |
Baxter International Inc. |
Implantable device
|
US5100392A
(en)
*
|
1989-12-08 |
1992-03-31 |
Biosynthesis, Inc. |
Implantable device for administration of drugs or other liquid solutions
|
US5843892A
(en)
*
|
1989-12-18 |
1998-12-01 |
California Institute Of Technology |
Stimulation of nerve growth and/or vitality
|
US5269785A
(en)
*
|
1990-06-28 |
1993-12-14 |
Bonutti Peter M |
Apparatus and method for tissue removal
|
US5618531A
(en)
*
|
1990-10-19 |
1997-04-08 |
New York University |
Method for increasing the viability of cells which are administered to the brain or spinal cord
|
DK0554352T3
(da)
*
|
1990-10-19 |
2003-06-10 |
Univ New York |
Fremgangsmåde til transplantation af celler ind i hjernen og terapeutiske anvendelser derfor.
|
BR9106205A
(pt)
*
|
1990-10-31 |
1993-03-30 |
Baxter Int |
Dispositivo para implantacao em hospedeiro,processo de implantacao,dispositivo implantado,e recipiente de imunoisolamento
|
US5314471A
(en)
*
|
1991-07-24 |
1994-05-24 |
Baxter International Inc. |
Tissue inplant systems and methods for sustaining viable high cell densities within a host
|
US5344454A
(en)
*
|
1991-07-24 |
1994-09-06 |
Baxter International Inc. |
Closed porous chambers for implanting tissue in a host
|
US5733336A
(en)
*
|
1990-10-31 |
1998-03-31 |
Baxter International, Inc. |
Ported tissue implant systems and methods of using same
|
US5713888A
(en)
*
|
1990-10-31 |
1998-02-03 |
Baxter International, Inc. |
Tissue implant systems
|
US5222982A
(en)
*
|
1991-02-11 |
1993-06-29 |
Ommaya Ayub K |
Spinal fluid driven artificial organ
|
WO1992013501A1
(en)
*
|
1991-02-11 |
1992-08-20 |
Ommaya Ayub K |
Spinal fluid driven artificial organ
|
DK0585368T3
(da)
|
1991-04-25 |
1998-03-16 |
Univ Brown Res Found |
Implanterbart biokompatibelt immunisolatorisk vehikel til afgivelse af udvalgte terapeutiske produkter
|
US5800829A
(en)
*
|
1991-04-25 |
1998-09-01 |
Brown University Research Foundation |
Methods for coextruding immunoisolatory implantable vehicles with a biocompatible jacket and a biocompatible matrix core
|
DK0586559T3
(da)
*
|
1991-05-21 |
1996-07-22 |
Univ Brown Res Found |
Hulfibre og indretning til brug ved fremstilling deraf
|
EP0586700A4
(de)
*
|
1991-05-24 |
1994-10-19 |
Sumitomo Pharma |
Instrument zum applizieren eines arzneimittels ins innere des gehirns.
|
EP0546158B1
(de)
*
|
1991-06-28 |
1998-01-07 |
Brown University Research Foundation |
Kapselextrusionssysteme
|
US5232712A
(en)
*
|
1991-06-28 |
1993-08-03 |
Brown University Research Foundation |
Extrusion apparatus and systems
|
US5453278A
(en)
*
|
1991-07-24 |
1995-09-26 |
Baxter International Inc. |
Laminated barriers for tissue implants
|
US6773458B1
(en)
*
|
1991-07-24 |
2004-08-10 |
Baxter International Inc. |
Angiogenic tissue implant systems and methods
|
US6503277B2
(en)
|
1991-08-12 |
2003-01-07 |
Peter M. Bonutti |
Method of transplanting human body tissue
|
US20040175795A1
(en)
*
|
1991-09-20 |
2004-09-09 |
Amgen Inc. |
Glial derived neurotrophic factor
|
ES2225819T3
(es)
*
|
1991-09-20 |
2005-03-16 |
Amgen Inc. |
Factor neurotrofico de origen glial.
|
JP3252361B2
(ja)
*
|
1991-10-02 |
2002-02-04 |
ミルトン・エイチ・リプスキー |
インビボにおける癌の治療のアッセイ
|
US5792900A
(en)
*
|
1991-10-21 |
1998-08-11 |
The Trustees Of The University Of Pennsylvania |
Compositions and methods for producing and using homogenous neuronal cell transplants
|
US6063630A
(en)
|
1991-11-05 |
2000-05-16 |
Transkaryotic Therapies, Inc. |
Targeted introduction of DNA into primary or secondary cells and their use for gene therapy
|
US6692737B1
(en)
|
1991-11-05 |
2004-02-17 |
Transkaryotic Therapies, Inc. |
In vivo protein production and delivery system for gene therapy
|
US6054288A
(en)
*
|
1991-11-05 |
2000-04-25 |
Transkaryotic Therapies, Inc. |
In vivo protein production and delivery system for gene therapy
|
NZ245015A
(en)
|
1991-11-05 |
1995-12-21 |
Transkaryotic Therapies Inc |
Delivery of human growth hormone through the administration of transfected cell lines encoding human growth hormone, which are physically protected from host immune response; the transfected cells and their production
|
US5733761A
(en)
|
1991-11-05 |
1998-03-31 |
Transkaryotic Therapies, Inc. |
Protein production and protein delivery
|
US6270989B1
(en)
|
1991-11-05 |
2001-08-07 |
Transkaryotic Therapies, Inc. |
Protein production and delivery
|
DE69320470T2
(de)
*
|
1992-04-24 |
1999-04-29 |
Polymer Technology Group Inc |
Copolymere, sowie daraus hergestellte nichtporöse halbdurchlässige membranen und ihre verwendung zum filtern von molekülen in einem vorgegebenen molekulargewichtbereich
|
EP0745121B1
(de)
*
|
1992-05-14 |
2007-06-20 |
Baylor College Of Medicine |
Mutierte steroidhormonrezeptoren, methoden für ihre benutzung und molekularer schalter für gentherapie
|
EP0641196B1
(de)
*
|
1992-05-29 |
2001-08-22 |
Vivorx, Incorporated |
Mikroverkapselung von zellen
|
US6670178B1
(en)
|
1992-07-10 |
2003-12-30 |
Transkaryotic Therapies, Inc. |
In Vivo production and delivery of insulinotropin for gene therapy
|
US6531124B1
(en)
|
1992-07-10 |
2003-03-11 |
Transkaryotic Therapies, Inc. |
In vivo production and delivery of insulinotropin for gene therapy
|
DE69331997T2
(de)
*
|
1992-09-28 |
2003-01-02 |
Univ Brown Res Found |
Chitozanmatrizes für eingekapselte zellen
|
US5871985A
(en)
*
|
1992-09-28 |
1999-02-16 |
Brown University Research Foundation |
Particulate non cross-linked chitosan core matrices for encapsulated cells
|
US5383873A
(en)
*
|
1992-12-09 |
1995-01-24 |
Regents Of The University Of Minnesota |
Smooth muscle chemical pacemaker
|
US5753491A
(en)
*
|
1993-04-13 |
1998-05-19 |
Us Health |
Use of neuro-derived fetal cell lines for transplantation therapy
|
PT696205E
(pt)
*
|
1993-04-13 |
2002-07-31 |
Us Gov Health & Human Serv |
Utilizacao de linhas celulares fetais nauro-derivadas para terapia de transplantacao
|
ATE190633T1
(de)
*
|
1993-04-27 |
2000-04-15 |
Cytotherapeutics Inc |
Membran aus einem acrylnitrilpolymer
|
US5698413A
(en)
*
|
1993-05-05 |
1997-12-16 |
The United States Of America As Represented By The Department Of Health And Human Services |
Method of evaluating chemotherapeutic agents in vivo
|
JPH09502620A
(ja)
*
|
1993-06-23 |
1997-03-18 |
ブラウン ユニヴァーシティ リサーチ ファンデーション |
移植可能な膜カプセル装置の密封方法及び装置
|
ES2138665T3
(es)
|
1993-08-10 |
2000-01-16 |
Gore & Ass |
Dispositivo para encapsular celulas.
|
EP1179350A3
(de)
*
|
1993-08-12 |
2003-01-02 |
Cytotherapeutics, Inc. |
Enkapsuliertes Zellsystem zur Implantation in dem menschlichen ZNC
|
US5908623A
(en)
*
|
1993-08-12 |
1999-06-01 |
Cytotherapeutics, Inc. |
Compositions and methods for the delivery of biologically active molecules using genetically altered cells contained in biocompatible immunoisolatory capsules
|
WO1995006486A1
(en)
*
|
1993-09-03 |
1995-03-09 |
Government Of The United States Of America, Secretary Department Of Health And Human Services |
Treatment of human tumors by genetic transformation of human tumor cells
|
JPH08503715A
(ja)
*
|
1993-09-24 |
1996-04-23 |
バクスター、インターナショナル、インコーポレイテッド |
埋め込み装置の血管化を促進するための方法
|
CA2176216A1
(en)
*
|
1993-11-09 |
1995-05-18 |
Virginia M.-Y. Lee |
Compositions and methods for producing and using homogeneous neuronal cell transplants
|
US5550050A
(en)
*
|
1994-04-15 |
1996-08-27 |
Cytotherapeutics, Inc. |
Method for implanting encapsulated cells in a host
|
US6156305A
(en)
*
|
1994-07-08 |
2000-12-05 |
Baxter International Inc. |
Implanted tumor cells for the prevention and treatment of cancer
|
EP0774929A4
(de)
*
|
1994-07-22 |
2000-09-27 |
Univ Washington |
Verfahren zur stereotaktischen implantation
|
US20030157074A1
(en)
*
|
1994-11-16 |
2003-08-21 |
Mitrani Eduardo N. |
Vitro micro-organs, and uses related thereto
|
US20030152909A1
(en)
*
|
1994-11-16 |
2003-08-14 |
Mitrani Eduardo N. |
In vitro micro-organs, and uses related thereto
|
JPH10513471A
(ja)
*
|
1995-02-10 |
1998-12-22 |
メドトロニック、インコーポレイテッド |
鎮痛薬投与のための方法と装置
|
WO1996032076A1
(en)
*
|
1995-04-11 |
1996-10-17 |
Baxter Internatonal Inc. |
Tissue implant systems
|
US7069634B1
(en)
|
1995-04-28 |
2006-07-04 |
Medtronic, Inc. |
Method for manufacturing a catheter
|
AU5545596A
(en)
*
|
1995-04-28 |
1996-11-18 |
Medtronic, Inc. |
Intraparenchymal infusion catheter system
|
US6132463A
(en)
|
1995-05-19 |
2000-10-17 |
Etex Corporation |
Cell seeding of ceramic compositions
|
US6060640A
(en)
*
|
1995-05-19 |
2000-05-09 |
Baxter International Inc. |
Multiple-layer, formed-in-place immunoisolation membrane structures for implantation of cells in host tissue
|
US5704910A
(en)
*
|
1995-06-05 |
1998-01-06 |
Nephros Therapeutics, Inc. |
Implantable device and use therefor
|
US5681740A
(en)
*
|
1995-06-05 |
1997-10-28 |
Cytotherapeutics, Inc. |
Apparatus and method for storage and transporation of bioartificial organs
|
US5837234A
(en)
*
|
1995-06-07 |
1998-11-17 |
Cytotherapeutics, Inc. |
Bioartificial organ containing cells encapsulated in a permselective polyether suflfone membrane
|
WO1997010807A1
(en)
*
|
1995-09-22 |
1997-03-27 |
Gore Hybrid Technologies, Inc. |
Improved cell encapsulation device
|
US5731284A
(en)
*
|
1995-09-28 |
1998-03-24 |
Amgen Inc. |
Method for treating Alzheimer's disease using glial line-derived neurotrophic factor (GDNF) protein product
|
US6184200B1
(en)
*
|
1995-09-28 |
2001-02-06 |
Amgen Inc. |
Truncated glial cell line-derived neurotrophic factor
|
US5855613A
(en)
*
|
1995-10-13 |
1999-01-05 |
Islet Sheet Medical, Inc. |
Retrievable bioartificial implants having dimensions allowing rapid diffusion of oxygen and rapid biological response to physiological change
|
ATE297702T1
(de)
*
|
1995-10-26 |
2005-07-15 |
Paul P Latta |
Induktion von immunologischer toleranz
|
US5641750A
(en)
*
|
1995-11-29 |
1997-06-24 |
Amgen Inc. |
Methods for treating photoreceptors using glial cell line-derived neurotrophic factor (GDNF) protein product
|
US5641749A
(en)
*
|
1995-11-29 |
1997-06-24 |
Amgen Inc. |
Method for treating retinal ganglion cell injury using glial cell line-derived neurothrophic factor (GDNF) protein product
|
US6110707A
(en)
*
|
1996-01-19 |
2000-08-29 |
Board Of Regents, The University Of Texas System |
Recombinant expression of proteins from secretory cell lines
|
US6087129A
(en)
|
1996-01-19 |
2000-07-11 |
Betagene, Inc. |
Recombinant expression of proteins from secretory cell lines
|
US5741778A
(en)
*
|
1996-03-19 |
1998-04-21 |
Amgen Inc. |
Method for treating Huntington's disease using glial cell line-derived neurotrophic factor (GDNF) protein product
|
US7138251B1
(en)
|
1996-04-22 |
2006-11-21 |
Amgen Inc. |
Polynucleotides encoding a neurotrophic factor receptor
|
US6455277B1
(en)
*
|
1996-04-22 |
2002-09-24 |
Amgen Inc. |
Polynucleotides encoding human glial cell line-derived neurotrophic factor receptor polypeptides
|
US6027721A
(en)
*
|
1996-05-20 |
2000-02-22 |
Cytotherapeutics, Inc. |
Device and method for encapsulated gene therapy
|
DK0912734T3
(da)
*
|
1996-07-12 |
2011-02-07 |
Genentech Inc |
Kimæriske heteromultimer-adhæsiner
|
DE69732711T2
(de)
*
|
1996-07-12 |
2006-03-16 |
Genentech, Inc., South San Francisco |
Gamma-heregulin
|
US6054142A
(en)
|
1996-08-01 |
2000-04-25 |
Cyto Therapeutics, Inc. |
Biocompatible devices with foam scaffolds
|
US6200589B1
(en)
|
1996-09-13 |
2001-03-13 |
The University Of Akron |
Biological implants of semipermeable amphiphilic membranes
|
AUPO251096A0
(en)
|
1996-09-23 |
1996-10-17 |
Cardiac Crc Nominees Pty Limited |
Polysiloxane-containing polyurethane elastomeric compositions
|
US8728536B2
(en)
*
|
1996-10-16 |
2014-05-20 |
Etex Corporation |
Chemotherapeutic composition using nanocrystalline calcium phosphate paste
|
US6593290B1
(en)
|
1996-11-01 |
2003-07-15 |
Genentech, Inc. |
Treatment of inner ear hair cells
|
US6156728A
(en)
|
1996-11-01 |
2000-12-05 |
Genentech, Inc. |
Treatment of inner ear hair cells
|
EP2002846B1
(de)
|
1996-12-06 |
2017-01-25 |
Amgen Inc. |
Kombinationstherapie mit einem IL-1-Inhibitor zur Behandlung von IL-1-vermittelten Krankheiten
|
AUPO431596A0
(en)
|
1996-12-20 |
1997-01-23 |
Scientec Research Pty Ltd |
Apparatus and method for coating a material
|
WO1999049807A2
(en)
|
1997-01-16 |
1999-10-07 |
Yissum Research And Development Company Of The Hebrew University Of Jerusalem |
A device and method for performing a biological modification of a fluid
|
US6416510B1
(en)
|
1997-03-13 |
2002-07-09 |
Biocardia, Inc. |
Drug delivery catheters that attach to tissue and methods for their use
|
US6547787B1
(en)
|
1997-03-13 |
2003-04-15 |
Biocardia, Inc. |
Drug delivery catheters that attach to tissue and methods for their use
|
US6128537A
(en)
*
|
1997-05-01 |
2000-10-03 |
Medtronic, Inc |
Techniques for treating anxiety by brain stimulation and drug infusion
|
AU7289898A
(en)
*
|
1997-05-07 |
1998-11-27 |
Neuralstem Biopharmaceuticals |
Embryonic and adult cns stem cells
|
US7048716B1
(en)
|
1997-05-15 |
2006-05-23 |
Stanford University |
MR-compatible devices
|
US6272370B1
(en)
|
1998-08-07 |
2001-08-07 |
The Regents Of University Of Minnesota |
MR-visible medical device for neurological interventions using nonlinear magnetic stereotaxis and a method imaging
|
US6026316A
(en)
*
|
1997-05-15 |
2000-02-15 |
Regents Of The University Of Minnesota |
Method and apparatus for use with MR imaging
|
US6061587A
(en)
*
|
1997-05-15 |
2000-05-09 |
Regents Of The University Of Minnesota |
Method and apparatus for use with MR imaging
|
US6254865B1
(en)
|
1997-06-17 |
2001-07-03 |
University Technology Corporation |
Method of treating huntington's disease using HNT neurons
|
US6121415A
(en)
*
|
1997-07-09 |
2000-09-19 |
Genentech, Inc. |
ErbB4 receptor-specific neuregolin related ligands and uses therefor
|
ZA986077B
(en)
|
1997-07-09 |
2000-01-10 |
Genentech Inc |
ErbB4 receptor-specific neuregulin related ligands and uses therefor.
|
US6994856B1
(en)
*
|
1997-07-24 |
2006-02-07 |
Genentech, Inc. |
ErbB4 receptor-specific neuregulin related ligands and uses therefor
|
AU8692598A
(en)
|
1997-08-04 |
1999-02-22 |
Calydon, Inc. |
A human glandular kallikrein enhancer, vectors comprising the enhancer and methods of use thereof
|
US6030358A
(en)
*
|
1997-08-08 |
2000-02-29 |
Odland; Rick Matthew |
Microcatheter and method for site specific therapy
|
US6042909A
(en)
*
|
1997-09-03 |
2000-03-28 |
Circe Biomedical, Inc. |
Encapsulation device
|
GB2329840C
(en)
*
|
1997-10-03 |
2007-10-05 |
Johnson & Johnson Medical |
Biopolymer sponge tubes
|
US7687057B2
(en)
|
1998-01-09 |
2010-03-30 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
In vitro micro-organs, and uses related thereto
|
DK1064382T3
(da)
|
1998-03-17 |
2008-12-08 |
Genentech Inc |
Homologe polypeptider til VEGF og BMP1
|
US7157083B2
(en)
*
|
1998-04-17 |
2007-01-02 |
Surrogate Pharmaceutical Pathways, Llc |
Compositions and methods for treating retroviral infections
|
US6463317B1
(en)
|
1998-05-19 |
2002-10-08 |
Regents Of The University Of Minnesota |
Device and method for the endovascular treatment of aneurysms
|
US5973119A
(en)
*
|
1998-06-05 |
1999-10-26 |
Amgen Inc. |
Cyclin E genes and proteins
|
US6787356B1
(en)
|
1998-07-24 |
2004-09-07 |
The United States Of America As Represented By The Department Of Health And Human Services |
Cell expansion system for use in neural transplantation
|
US6344541B1
(en)
|
1998-09-25 |
2002-02-05 |
Amgen Inc. |
DKR polypeptides
|
US6291516B1
(en)
*
|
1999-01-13 |
2001-09-18 |
Curis, Inc. |
Regulators of the hedgehog pathway, compositions and uses related thereto
|
US6303749B1
(en)
|
1999-01-29 |
2001-10-16 |
Amgen Inc. |
Agouti and agouti-related peptide analogs
|
US7708993B2
(en)
*
|
1999-02-03 |
2010-05-04 |
Amgen Inc. |
Polypeptides involved in immune response
|
US7435796B1
(en)
|
1999-02-03 |
2008-10-14 |
Amgen Inc. |
Antibodies which bind B7RP1
|
US8624010B1
(en)
|
1999-02-03 |
2014-01-07 |
Steven K. Yoshinaga |
Nucleic acids encoding B7RP1
|
CA2640956C
(en)
|
1999-02-03 |
2012-07-03 |
Amgen Inc. |
B7rp-1 polypeptides
|
ATE482717T1
(de)
|
1999-02-10 |
2010-10-15 |
Curis Inc |
Peptid yy (pyy) zur behandlung von glukose stoffwechselkrankheiten
|
US7745216B2
(en)
*
|
1999-02-10 |
2010-06-29 |
Curis, Inc. |
Methods and reagents for treating glucose metabolic disorders
|
AU3770800A
(en)
|
1999-03-26 |
2000-10-16 |
Amgen, Inc. |
Beta secretase genes and polypeptides
|
US20070071734A1
(en)
*
|
1999-04-06 |
2007-03-29 |
Weng Tao |
ARPE-19 as platform cell line for encapsulated cell-based delivery
|
US6361771B1
(en)
|
1999-04-06 |
2002-03-26 |
Neurotech S.A. |
ARPE-19 as a platform cell line for encapsulated cell-based delivery
|
US6176242B1
(en)
|
1999-04-30 |
2001-01-23 |
Medtronic Inc |
Method of treating manic depression by brain infusion
|
US6109269A
(en)
*
|
1999-04-30 |
2000-08-29 |
Medtronic, Inc. |
Method of treating addiction by brain infusion
|
EP1190082A4
(de)
*
|
1999-06-25 |
2003-07-02 |
Yissum Res Dev Co |
Verfahren zur induktion von angiogenese mittels mikroorganen
|
DK1189641T5
(da)
|
1999-06-25 |
2011-04-11 |
Genentech Inc |
Humaniserede ANTI-ErbB2-antistoffer og behandling med ANTI-ErbB2-antistoffer
|
US7459540B1
(en)
*
|
1999-09-07 |
2008-12-02 |
Amgen Inc. |
Fibroblast growth factor-like polypeptides
|
US7408047B1
(en)
|
1999-09-07 |
2008-08-05 |
Amgen Inc. |
Fibroblast growth factor-like polypeptides
|
US20030103978A1
(en)
|
2000-02-23 |
2003-06-05 |
Amgen Inc. |
Selective binding agents of osteoprotegerin binding protein
|
US20050239061A1
(en)
*
|
2000-03-01 |
2005-10-27 |
Marshall William S |
Identification and use of effectors and allosteric molecules for the alteration of gene expression
|
TWI322154B
(en)
|
2000-03-16 |
2010-03-21 |
Amgen Inc |
Il-17 receptor like molecules and uses thereof
|
US7514239B2
(en)
|
2000-03-28 |
2009-04-07 |
Amgen Inc. |
Nucleic acid molecules encoding beta-like glycoprotein hormone polypeptides and heterodimers thereof
|
US7115653B2
(en)
*
|
2000-03-30 |
2006-10-03 |
Curis, Inc. |
Small organic molecule regulators of cell proliferation
|
US6683108B1
(en)
*
|
2000-03-30 |
2004-01-27 |
Curis, Inc. |
Agonists of hedgehog signaling pathways and uses related thereto
|
US6613798B1
(en)
|
2000-03-30 |
2003-09-02 |
Curis, Inc. |
Small organic molecule regulators of cell proliferation
|
US20050070578A1
(en)
*
|
2000-03-30 |
2005-03-31 |
Baxter Anthony David |
Small organic molecule regulators of cell proliferation
|
US8852937B2
(en)
*
|
2000-03-30 |
2014-10-07 |
Curis, Inc. |
Small organic molecule regulators of cell proliferation
|
US6478776B1
(en)
|
2000-04-05 |
2002-11-12 |
Biocardia, Inc. |
Implant delivery catheter system and methods for its use
|
BR0110610A
(pt)
|
2000-04-11 |
2003-04-29 |
Genentech Inc |
Anticorpos isolados, imunoconjugados, cadeias de polipeptìdeos, ácido nucléico isolado, vetor, célula hospedeira, processo de produção de anticorpo ou cadeia de polipeptìdeos, método de tratamento de disfunções em mamìferos, método de indução da apoptose de uma célula cancerosa, método para matar uma célula b, método para matar uma célula que expresse um receptor de erbb e usos dos anticorpos isolados
|
AU2001268363B2
(en)
|
2000-06-20 |
2006-08-17 |
Biogen Idec Inc. |
Treatment of B cell associated diseases
|
EP2792747A1
(de)
|
2000-06-23 |
2014-10-22 |
Genentech, Inc. |
Zusammensetzungen und Verfahren zur Diagnose und Behandlung von Erkrankungen in Verbindung mit Angiogenese
|
EP2075253A1
(de)
|
2000-06-23 |
2009-07-01 |
Genentech, Inc. |
Methoden und Verbindungen zur Diagnose und Behandlung von Krankheiten, an denen Angiogenese beteiligt ist
|
DE60137223D1
(de)
|
2000-06-28 |
2009-02-12 |
Amgen Inc |
Thymus-stroma lymphopoietin rezeptor-moleküle und deren verwendung
|
US20090209831A1
(en)
*
|
2000-06-28 |
2009-08-20 |
Nexgen Medical Systems, Incorporated |
Imaging methods for visualizing implanted living cells
|
AU2001271618B8
(en)
*
|
2000-06-28 |
2006-04-27 |
Amgen, Inc. |
B7-Like molecules and uses thereof
|
EP1978090A1
(de)
|
2000-08-09 |
2008-10-08 |
ES Cell International Pte Ltd. |
Pankreatische Vorläuferzellen
|
US6908732B2
(en)
|
2000-10-13 |
2005-06-21 |
President & Fellows Of Harvard College |
Compounds and methods for regulating cell differentiation
|
US6871098B2
(en)
*
|
2000-10-30 |
2005-03-22 |
Medtronic, Inc. |
Method for treating obsessive-compulsive disorder with electrical stimulation of the brain internal capsule
|
MXPA03004578A
(es)
|
2000-11-28 |
2004-05-05 |
Amgen Inc |
Nuevos polipeptidos involucrados en respuesta inmune.
|
JP2004515533A
(ja)
*
|
2000-12-14 |
2004-05-27 |
アミリン・ファーマシューティカルズ,インコーポレイテッド |
代謝障害を治療するためのペプチドyyおよびペプチドyyアゴニスト
|
CZ298160B6
(cs)
*
|
2001-01-18 |
2007-07-11 |
|
Prístroj pro vyvolání imunitní odezvy pri lécbe rakoviny
|
US20020159996A1
(en)
|
2001-01-31 |
2002-10-31 |
Kandasamy Hariharan |
Use of CD23 antagonists for the treatment of neoplastic disorders
|
KR101012952B1
(ko)
*
|
2001-02-14 |
2011-02-08 |
안트로제네시스 코포레이션 |
산후 포유류의 태반, 이의 용도 및 태반 줄기세포
|
CA2633171C
(en)
|
2001-06-20 |
2012-11-20 |
Genentech, Inc. |
Antibodies against tumor-associated antigenic target (tat) polypeptides
|
DE60235989D1
(de)
|
2001-06-26 |
2010-05-27 |
Amgen Fremont Inc |
Antikörper gegen opgl
|
EP1414517A4
(de)
*
|
2001-06-26 |
2008-02-06 |
Photomed Technologies Inc |
Mehrfach-wellenlängen-illuminator
|
EP1411769A4
(de)
*
|
2001-07-09 |
2004-12-29 |
Medgenics Inc |
Wirkungsvolle verfahren zur beurteilung und validierung von durch interessierende nukleinsäuresequenzen codierten therapeutischen kandidatenmolekülen auf proteinbasis
|
EP1639972B1
(de)
|
2001-08-01 |
2013-09-11 |
Anecova SA |
Intrauterine Vorrichtung
|
EP1572887A4
(de)
|
2001-08-24 |
2008-12-24 |
Neuren Pharmaceuticals Ltd |
Nervenregenerierungspeptid und verfahren zu deren verwendung bei der behandlung einer hirnschädigung
|
US20040235068A1
(en)
*
|
2001-09-05 |
2004-11-25 |
Levinson Arthur D. |
Methods for the identification of polypeptide antigens associated with disorders involving aberrant cell proliferation and compositions useful for the treatment of such disorders
|
DE60238143D1
(de)
|
2001-09-18 |
2010-12-09 |
Genentech Inc |
Zusammensetzungen und verfahren für die diagnose von tumoren
|
US8088568B2
(en)
|
2001-11-05 |
2012-01-03 |
Medgentics, Inc. |
Dermal micro-organs, methods and apparatuses for producing and using the same
|
US8501396B2
(en)
|
2001-11-05 |
2013-08-06 |
Medgenics Medical Israel Ltd. |
Dermal micro-organs, methods and apparatuses for producing and using the same
|
US7468242B2
(en)
|
2001-11-05 |
2008-12-23 |
Medgenics, Inc. |
Dermal micro organs, methods and apparatuses for producing and using the same
|
US6758828B2
(en)
|
2001-12-10 |
2004-07-06 |
Regents Of The University Of Minnesota |
Catheter for cell delivery in tissue
|
WO2003057160A2
(en)
|
2002-01-02 |
2003-07-17 |
Genentech, Inc. |
Compositions and methods for the diagnosis and treatment of tumor
|
AU2003217693A1
(en)
*
|
2002-02-22 |
2003-09-09 |
Board Of Trustees Of The University Of Illinois |
Beta chain-associated regulator of apoptosis
|
US7662924B2
(en)
*
|
2002-02-22 |
2010-02-16 |
The Board Of Trustees Of The University Of Illinois |
Beta chain-associated regulator of apoptosis
|
US7718776B2
(en)
|
2002-04-05 |
2010-05-18 |
Amgen Inc. |
Human anti-OPGL neutralizing antibodies as selective OPGL pathway inhibitors
|
MXPA04010092A
(es)
|
2002-04-16 |
2004-12-13 |
Genentech Inc |
Composiciones y metodos para el diagnostico y tratamiento de tumores.
|
ATE404200T1
(de)
|
2002-04-22 |
2008-08-15 |
Univ Johns Hopkins Med |
Modulatoren von hedgehog signalpfaden, zusammensetzungen und verwandte verwendungen
|
EP2305710A3
(de)
|
2002-06-03 |
2013-05-29 |
Genentech, Inc. |
Synthetische Antikörperphagenbibliotheken
|
AU2003251397B2
(en)
|
2002-06-05 |
2009-10-01 |
Genentech, Inc. |
Compositions and methods for liver growth and liver protection
|
US7705195B2
(en)
*
|
2002-06-07 |
2010-04-27 |
Genentech, Inc. |
Screening method
|
DE60335639D1
(de)
*
|
2002-06-14 |
2011-02-17 |
Amylin Pharmaceuticals Inc |
Prävention und/oder behandlung von colitis ulcerosa mit pyy oder pyyä3-36ü
|
JP2005533102A
(ja)
*
|
2002-07-12 |
2005-11-04 |
イッサム リサーチ ディベロップメント カンパニー オブ ザ ヘブリュー ユニバーシティー オブ エルサレム |
微小器官によって生物学的プロセスを誘発する方法と装置
|
ES2376165T3
(es)
|
2002-07-15 |
2012-03-09 |
F. Hoffmann-La Roche Ag |
Tratamiento del c�?ncer con el anticuerpo dirigido contra erbb2 rhumab 2c4.
|
WO2004031347A2
(en)
*
|
2002-09-24 |
2004-04-15 |
Massachusetts Institute Of Technology |
Methods and compositions for soluble cpg15
|
CN1787837A
(zh)
|
2002-11-15 |
2006-06-14 |
希龙公司 |
防止和治疗癌转移以及与癌转移相关的骨质损失的方法
|
WO2004096124A2
(en)
|
2003-04-01 |
2004-11-11 |
Genentech, Inc. |
Compositions and methods for the diagnosis and treatment of tumor
|
ZA200507805B
(en)
|
2003-04-09 |
2006-12-27 |
Genentech Inc |
Therapy of autoimmune disease in a patient with an inadequate response to a TNF-alpha inhibitor
|
CA2521623C
(en)
*
|
2003-04-11 |
2015-03-17 |
Etex Corporation |
Osteoinductive bone material
|
US7241283B2
(en)
*
|
2003-04-25 |
2007-07-10 |
Ad-Tech Medical Instrument Corp. |
Method for intracranial catheter treatment of brain tissue
|
PT1653807E
(pt)
|
2003-05-01 |
2012-07-23 |
Medgenics Inc |
Micro-órgãos dérmicos, métodos e dispositivos para produção e utilização dos mesmos
|
US7619068B2
(en)
|
2003-05-09 |
2009-11-17 |
Diadexus, Inc. |
Ovr110 antibody compositions and methods of use
|
AU2004265226A1
(en)
*
|
2003-05-16 |
2005-02-24 |
Receptor Biologix, Inc. |
Intron fusion proteins, and methods of identifying and using same
|
EP1629014A2
(de)
*
|
2003-05-30 |
2006-03-01 |
Genentech, Inc. |
Polypeptide, die einen antigewebefaktorantikörper binden und deren verwendungen
|
ES2323066T3
(es)
|
2003-06-10 |
2009-07-06 |
Nsgene A/S |
Secrecion mejorada de neublastina.
|
CA2432810A1
(en)
|
2003-06-19 |
2004-12-19 |
Andres M. Lozano |
Method of treating depression, mood disorders and anxiety disorders by brian infusion
|
US8501473B2
(en)
|
2003-07-16 |
2013-08-06 |
Evotec International Gmbh |
Use of pleitrophin for preventing and treating pancreatic diseases and/or obesity and/or metabolic syndrome
|
AU2004264601A1
(en)
|
2003-07-29 |
2005-02-24 |
Genentech, Inc. |
Assay for human anti CD20 antibodies and uses therefor
|
ATE536186T1
(de)
|
2003-09-12 |
2011-12-15 |
Tercica Inc |
Verfahren zur behandlung von igf-1 (insulin-like growth factor 1)-mangel
|
WO2005032476A2
(en)
*
|
2003-09-30 |
2005-04-14 |
Massachusetts Institute Of Technology |
Methods and compositions for cpg15-2
|
BRPI0415563A
(pt)
|
2003-10-20 |
2007-01-02 |
Nsgene As |
método para o tratamento do mal de parkinson, uso de um vetor viral, vetor de expressão viral, composição farmacêutica, célula hospedeira isolada, linhagem de células de empacotamento, mamìfero não humano quimérico, dispositivo de cultura celular implantável, cápsula biocompatìvel, método para tratamento de uma doença do sistema nervoso, célula de mamìfero, e, método para produzir neurturin ou um seu equivalente funcional
|
EP1689432B1
(de)
|
2003-11-17 |
2009-12-30 |
Genentech, Inc. |
Zusammensetzungen und verfahren zur behandlung von tumoren hämatopoetischen ursprungs
|
EP2311873B1
(de)
|
2004-01-07 |
2018-08-29 |
Novartis Vaccines and Diagnostics, Inc. |
M-csf spezifischer monoclonaler antikörper und dessen verwendungen
|
DK1709161T3
(da)
*
|
2004-01-19 |
2009-01-26 |
Nsgene As |
Humane terapeutiske celler, som udskiller nervevækstfaktor
|
JP5638177B2
(ja)
*
|
2004-02-11 |
2014-12-10 |
アミリン・ファーマシューティカルズ, リミテッド・ライアビリティ・カンパニーAmylin Pharmaceuticals, Llc |
膵臓ポリペプチドファミリーモチーフおよびそのモチーフを含むポリペプチド
|
KR101204286B1
(ko)
|
2004-03-30 |
2012-11-26 |
엔에스진 에이/에스 |
성장 인자 NsG33의 치료학적 용도
|
EP1742648A4
(de)
*
|
2004-04-15 |
2009-03-04 |
Etex Corp |
Calciumphosphatpasten mit verzögerter härtung
|
AU2005247303A1
(en)
*
|
2004-04-16 |
2005-12-08 |
Genentech, Inc. |
Treatment of polychondritis and mononeuritis multiplex with anti-CD20 antibodies
|
US20150017671A1
(en)
|
2004-04-16 |
2015-01-15 |
Yaping Shou |
Methods for detecting lp-pla2 activity and inhibition of lp-pla2 activity
|
EP1750800A1
(de)
*
|
2004-04-30 |
2007-02-14 |
Advanced Neuromodulation Systems, Inc. |
Verfahren zur behandlung von stimmungsstörungen und/oder angststörungen durch stimulation des gehirns
|
US20060286102A1
(en)
*
|
2004-05-14 |
2006-12-21 |
Pei Jin |
Cell surface receptor isoforms and methods of identifying and using the same
|
RU2384345C2
(ru)
|
2004-06-04 |
2010-03-20 |
Дженентек, Инк. |
Способ лечения рассеянного склероза
|
CA2897218A1
(en)
|
2004-06-17 |
2006-01-26 |
Thrasos Innovation, Inc. |
Tdf-related compounds and analogs thereof
|
US20090136552A1
(en)
*
|
2004-07-30 |
2009-05-28 |
Mette Gronborg |
Growth factors nsg28, nsg30, and nsg32
|
US20070072294A1
(en)
*
|
2004-09-30 |
2007-03-29 |
Doronin Sergey V |
Use of human stem cells and/or factors they produce to promote adult mammalian cardiac repair through cardiomyocyte cell division
|
CA2583308C
(en)
*
|
2004-10-08 |
2020-01-07 |
Georgia Tech Research Corporation |
Microencapsulation of cells in hydrogels using electrostatic potentials
|
US9051342B2
(en)
|
2004-10-13 |
2015-06-09 |
Ptc Therapeutics, Inc. |
Pyrazole or triazole compounds and their use for the manufacture of a medicament for treating somatic mutation related diseases
|
US7998930B2
(en)
|
2004-11-04 |
2011-08-16 |
Hanall Biopharma Co., Ltd. |
Modified growth hormones
|
JP2008526762A
(ja)
*
|
2004-12-30 |
2008-07-24 |
プライムジェン バイオテック エルエルシー |
組織再生および創傷治癒のための脂肪由来幹細胞
|
DE602006013275D1
(de)
|
2005-01-07 |
2010-05-12 |
Diadexus Inc |
Ovr110-antikörperzusammensetzungen und verwendungsverfahren dafür
|
US7713542B2
(en)
|
2005-01-14 |
2010-05-11 |
Ada Foundation |
Three dimensional cell protector/pore architecture formation for bone and tissue constructs
|
KR20190110637A
(ko)
|
2005-01-21 |
2019-09-30 |
제넨테크, 인크. |
Her 항체의 고정 용량 투여법
|
WO2006081171A1
(en)
*
|
2005-01-24 |
2006-08-03 |
Amgen Inc. |
Humanized anti-amyloid antibody
|
SI1850874T1
(sl)
|
2005-02-23 |
2014-01-31 |
Genentech, Inc. |
Podaljšanje časa za napredovanje bolezni ali za preživetje pri pacientkah z rakom na jajčnikih ob uporabi pertuzumaba
|
WO2006094072A2
(en)
*
|
2005-03-01 |
2006-09-08 |
Functional Neuroscience Inc. |
Method of treating cognitive disorders using neuromodulation
|
CA2599959A1
(en)
*
|
2005-03-01 |
2006-09-08 |
Functional Neuroscience Inc. |
Method of treating depression, mood disorders and anxiety disorders using neuromodulation
|
WO2006096861A2
(en)
*
|
2005-03-08 |
2006-09-14 |
Genentech, Inc. |
METHODS FOR IDENTIFYING TUMORS RESPONSIVE TO TREATMENT WITH HER DIMERIZATION INHIBITORS (HDIs)
|
CN101175769A
(zh)
|
2005-03-10 |
2008-05-07 |
健泰科生物技术公司 |
用于调控血管完整性的方法和组合物
|
EP2460875A1
(de)
|
2005-03-31 |
2012-06-06 |
Stemnion, Inc. |
Aus Amnion stammende Zellzusammensetzungen, Verfahren zur Herstellung und deren Verwendung
|
EP1869162A1
(de)
*
|
2005-04-01 |
2007-12-26 |
NsGene A/S |
Menschliche immortalisierte neurale vorläuferzellinie
|
AU2006235695B2
(en)
|
2005-04-09 |
2011-10-13 |
Fusion Antibodies Limited |
Cathepsin S antibody
|
US20080207594A1
(en)
|
2005-05-04 |
2008-08-28 |
Davelogen Aktiengesellschaft |
Use of Gsk-3 Inhibitors for Preventing and Treating Pancreatic Autoimmune Disorders
|
WO2006120580A2
(en)
*
|
2005-05-04 |
2006-11-16 |
Nautilus Biotech |
Modified interferon-gamma polypeptides and methods for using modified interferon-gamma polypeptides
|
WO2006119510A2
(en)
*
|
2005-05-04 |
2006-11-09 |
Receptor Biologix, Inc. |
Isoforms of receptor for advanced glycation end products (rage) and methods of identifying and using same
|
US20090170769A1
(en)
*
|
2005-05-13 |
2009-07-02 |
Pei Jin |
Cell surface receptor isoforms and methods of identifying and using the same
|
WO2006122549A2
(en)
*
|
2005-05-17 |
2006-11-23 |
Nsgene A/S |
An implantable therapy system comprising a gripping element
|
KR101502920B1
(ko)
|
2005-06-21 |
2015-03-17 |
조마 (유에스) 엘엘씨 |
IL-1β 결합성 항체 및 그의 단편
|
EP1913027B1
(de)
*
|
2005-07-28 |
2015-03-04 |
Novartis AG |
M-csf-spezifische monoklonale antikörper und anwendungen davon
|
EP1913028B1
(de)
*
|
2005-07-28 |
2015-03-04 |
Novartis AG |
Anwendung von antikörpern gegen m-csf
|
KR101691692B1
(ko)
|
2005-10-21 |
2016-12-30 |
카탈리스트 바이오사이언시즈, 인코포레이티드 |
보체 활성화를 억제하는 변형된 프로테아제
|
US8986781B2
(en)
*
|
2005-10-27 |
2015-03-24 |
Corning Incorporated |
Immobilized multi-layer artificial membrane for permeability measurements (PAMPA)
|
JP2009513584A
(ja)
*
|
2005-10-28 |
2009-04-02 |
エヌエスゲーネ・アクティーゼルスカブ |
Gdnfの送達のための移植可能な生体適合性免疫隔離ビヒクル
|
KR20080082629A
(ko)
*
|
2005-11-10 |
2008-09-11 |
리셉터 바이오로직스 인크 |
간세포 성장인자 인트론 융합 단백질
|
US8147860B2
(en)
|
2005-12-06 |
2012-04-03 |
Etex Corporation |
Porous calcium phosphate bone material
|
EP1969003B8
(de)
|
2005-12-14 |
2010-11-10 |
Hermo Pharma Ltd. |
Verwendungen eines neurotrophischen Faktors
|
JP5247468B2
(ja)
*
|
2005-12-30 |
2013-07-24 |
ニューロテック ユーエスエー, インコーポレイテッド |
生物活性分子の送達のための微粒子化デバイスおよびその使用方法
|
US20090081296A1
(en)
*
|
2006-02-02 |
2009-03-26 |
Humes H David |
Extracorporeal cell-based therapeutic device and delivery system
|
WO2007092735A2
(en)
|
2006-02-02 |
2007-08-16 |
Innovative Bio Therapies |
An extracorporeal cell-based therapeutic device and delivery system
|
US7884078B2
(en)
*
|
2006-02-10 |
2011-02-08 |
Massachusetts Institute Of Technology |
CPG15 compounds as insulin receptor and insulin-like growth factor receptor agonists
|
GB0604187D0
(en)
*
|
2006-03-02 |
2006-04-12 |
Fusion Antibodies Ltd |
Peptide and uses thereof
|
EP2389946A1
(de)
|
2006-03-23 |
2011-11-30 |
Novartis AG |
Antitumorzellenantigen-Antikörper-Therapeutika
|
WO2007110231A2
(en)
*
|
2006-03-28 |
2007-10-04 |
Nautilus Biotech, S.A. |
MODIFIED INTERFERON-β (IFN-β) POLYPEPTIDES
|
WO2007126455A2
(en)
|
2006-04-05 |
2007-11-08 |
Genentech, Inc. |
Method for using boc/cdo to modulate hedgehog signaling
|
BRPI0710055A2
(pt)
*
|
2006-04-10 |
2011-08-02 |
Fusion Antibodies Ltd |
métodos de inibir regulação ascendente induzida por quimioterapia de catepsina s, expressão de catepsina s sobre a superfìcie de células de tumor e angiogênese em um grupo de células, um tecido ou um órgão, de tratar doença neoplásica e uma condição associada com atividade de catepsina s em um paciente, de induzir reação citotóxica mediada por célula dependente de anticorpo contra uma célula de tumor, de matar células de tumor, de identificar células de tumor em uma população de células e de avaliar in vitro a resposta de células de tumor de um indivìduo à presença de um agente quimioterápico, usos de um inibidor de catepsina s e um agente quimioterapêutico, de catepsina s, de um anticorpo anti-catepsina s ou um fragmento do mesmo e de uma molécula de anticorpo, composição farmacêutica, kit farmacêutico e molécula de anticorpo ou um ácido nucleico codificando dita molécula de anticorpo
|
GB0620255D0
(en)
*
|
2006-10-12 |
2006-11-22 |
Fusion Antibodies Ltd |
Antibody and uses thereof
|
JP2009536526A
(ja)
|
2006-05-04 |
2009-10-15 |
ジェネンテック・インコーポレーテッド |
Zpaポリペプチドに関連する方法および組成物
|
US20100030102A1
(en)
*
|
2006-05-15 |
2010-02-04 |
David Poston |
Active Delivery and Flow Redirections: Novel Devices and Method of Delivery of Materials to Patients
|
US7998128B2
(en)
|
2006-05-15 |
2011-08-16 |
Therataxis, LLC. |
Active delivery and flow redirection: novel devices and method of delivery of materials to patients
|
EP2423307A1
(de)
|
2006-06-19 |
2012-02-29 |
Catalyst Biosciences, Inc. |
Modifizierte Gerinnungsfaktor-IV-Polypeptide und deren Verwendung bei der Behandlung
|
JP4546578B2
(ja)
|
2006-07-05 |
2010-09-15 |
カタリスト・バイオサイエンシーズ・インコーポレイテッド |
プロテアーゼスクリーニング方法およびそれにより同定されるプロテアーゼ
|
EP3415532A1
(de)
|
2006-08-18 |
2018-12-19 |
XOMA Technology Ltd. |
Prlr-spezifischer antikörper und verwendungen davon
|
US9127084B2
(en)
|
2006-09-14 |
2015-09-08 |
Medgenics Medical Israel Ltd. |
Long lasting drug formulations
|
CA2664318C
(en)
*
|
2006-09-14 |
2017-05-23 |
Andrew L. Pearlman |
Long lasting drug formulations
|
US8454948B2
(en)
|
2006-09-14 |
2013-06-04 |
Medgenics Medical Israel Ltd. |
Long lasting drug formulations
|
AU2007306139B2
(en)
*
|
2006-10-11 |
2014-02-27 |
Fusion Antibodies Limited |
Combination therapy
|
US20110218176A1
(en)
|
2006-11-01 |
2011-09-08 |
Barbara Brooke Jennings-Spring |
Compounds, methods, and treatments for abnormal signaling pathways for prenatal and postnatal development
|
US20090214474A1
(en)
*
|
2006-11-01 |
2009-08-27 |
Barbara Brooke Jennings |
Compounds, methods, and treatments for abnormal signaling pathways for prenatal and postnatal development
|
EP2962697A1
(de)
|
2006-11-27 |
2016-01-06 |
diaDexus, Inc. |
Ovr110-antikörperzusammensetzungen und verfahren zur verwendung
|
JP2010510794A
(ja)
|
2006-11-28 |
2010-04-08 |
ハナル ファーマシューティカル カンパニー リミテッド |
修飾型エリスロポエチンポリペプチド及びこの治療用用途
|
BRPI0720437A2
(pt)
|
2006-12-07 |
2014-01-07 |
Novartis Ag |
Anticorpos antafonísticos contra ephb3
|
US8221741B2
(en)
|
2007-01-17 |
2012-07-17 |
Marshall Vivienne S |
Methods for modulating inflammatory and/or immune responses
|
PE20130588A1
(es)
*
|
2007-02-02 |
2013-05-21 |
Amgen Inc |
Hepcidina, antagonistas de la hepcidina y metodos de uso
|
CN103432580A
(zh)
|
2007-03-02 |
2013-12-11 |
健泰科生物技术公司 |
基于低her3表达预测对her二聚化抑制剂的响应
|
RU2571931C2
(ru)
|
2007-04-13 |
2015-12-27 |
Каталист Биосайенсис, Инк. |
Полипептиды на основе модифицированного фактора vii и их применение
|
WO2008137281A1
(en)
*
|
2007-05-03 |
2008-11-13 |
Fox Chase Cancer Center |
Compositions and methods for altering pancreas or liver function
|
WO2008137280A1
(en)
*
|
2007-05-03 |
2008-11-13 |
Fox Chase Cancer Center |
Compositions and methods for altering pancreas or liver function
|
US9265577B2
(en)
|
2007-05-18 |
2016-02-23 |
The Johns Hopkins University |
Methods and systems for providing planning and dispensation of research and/or treatment for brain disease
|
ES2381788T3
(es)
|
2007-07-16 |
2012-05-31 |
Genentech, Inc. |
Anticuerpos anti-CD79b e inmunoconjugados y métodos de uso
|
SG183044A1
(en)
|
2007-07-16 |
2012-08-30 |
Genentech Inc |
Humanized anti-cd79b antibodies and immunoconjugatesand methods of use
|
FI20070808A0
(fi)
|
2007-10-25 |
2007-10-25 |
Mart Saarma |
GDNF:n silmukointivariantit ja niiden käytöt
|
WO2009073891A1
(en)
*
|
2007-12-07 |
2009-06-11 |
Northstar Neuroscience, Inc. |
Systems and methods for providing targeted neural stimulation therapy to address neurological disorders, including neuropyschiatric and neuropyschological disorders
|
US8414893B2
(en)
|
2007-12-21 |
2013-04-09 |
Amgen Inc. |
Anti-amyloid antibodies and uses thereof
|
UA106586C2
(uk)
|
2008-01-31 |
2014-09-25 |
Дженентек, Інк. |
Анти-cd79b антитіла, і імунокон'югати та способи їх застосування
|
US20090196854A1
(en)
*
|
2008-02-04 |
2009-08-06 |
Kytos Biosystems S.A. |
Methods and compositions for use of crl 5803 cells for expression of biotherapeutics and encapsulated cell-based delivery
|
TWI465247B
(zh)
|
2008-04-11 |
2014-12-21 |
Catalyst Biosciences Inc |
經修飾的因子vii多肽和其用途
|
GB0807018D0
(en)
*
|
2008-04-17 |
2008-05-21 |
Fusion Antibodies Ltd |
Antibodies and treatment
|
FI20080326A0
(fi)
|
2008-04-30 |
2008-04-30 |
Licentia Oy |
Neurotroofinen tekijä MANF ja sen käytöt
|
JOP20190083A1
(ar)
|
2008-06-04 |
2017-06-16 |
Amgen Inc |
بولي ببتيدات اندماجية طافرة لـfgf21 واستخداماتها
|
US9144584B2
(en)
|
2008-06-11 |
2015-09-29 |
Cell4Vet Corporation |
Adipose tissue-derived stem cells for veterinary use
|
WO2010071692A2
(en)
*
|
2008-06-18 |
2010-06-24 |
Innovative Biotherapies, Inc. |
Methods for enhanced propagation of cells
|
CA2729351C
(en)
|
2008-06-30 |
2017-01-24 |
University Of Pennsylvania |
Fn14/trail fusion proteins
|
EP2318036B1
(de)
|
2008-06-30 |
2015-06-03 |
The Regents of the University of Michigan |
Aktivität von lysosomaler phospholipase a2 (lpla2) als diagnostisches und therapeutisches target zur identifizierung und behandlung von systemischem lupus erythematodes
|
ES2332169B1
(es)
|
2008-07-24 |
2010-10-25 |
Universidad Del Pais Vasco |
Empleo de microparticulas que comprenden celulas modificadas geneticamente en el tratamiento de enfermedades neurodegenerativas.
|
TW201014605A
(en)
|
2008-09-16 |
2010-04-16 |
Genentech Inc |
Methods for treating progressive multiple sclerosis
|
CN102625811B
(zh)
|
2008-10-10 |
2016-09-21 |
安姆根有限公司 |
Fgf21突变体及其用途
|
WO2010075249A2
(en)
|
2008-12-22 |
2010-07-01 |
Genentech, Inc. |
A method for treating rheumatoid arthritis with b-cell antagonists
|
WO2010083842A2
(en)
|
2009-01-23 |
2010-07-29 |
Nsgene A/S |
Expression of neuropeptides in mammalian cells
|
CN102361971A
(zh)
|
2009-01-23 |
2012-02-22 |
Ns基因公司 |
改善的细胞系以及在胶囊化细胞生物递送中的用途
|
GB0902916D0
(en)
|
2009-02-20 |
2009-04-08 |
Fusion Antibodies Ltd |
Antibody therapy
|
CA2755198A1
(en)
|
2009-03-13 |
2010-09-16 |
Mark L. Tykocinski |
Ox40/trail fusion proteins
|
MX2011009797A
(es)
|
2009-03-20 |
2012-01-12 |
Amgen Inc |
Inhibidores peptidicos de kv1.3 potentes selectivos.
|
RU2587621C2
(ru)
|
2009-04-01 |
2016-06-20 |
Дженентек, Инк. |
АНТИТЕЛА К FcRH5, ИХ ИММУНОКОНЪЮГАТЫ И СПОСОБЫ ИХ ПРИМЕНЕНИЯ
|
JP2012524544A
(ja)
*
|
2009-04-23 |
2012-10-18 |
ニューロテック ユーエスエー, インコーポレイテッド |
プロスタグランジンF2アルファ(PGF2a)を産生する細胞系およびその使用
|
EA021425B1
(ru)
|
2009-05-05 |
2015-06-30 |
Амген Инк. |
Мутанты fgf21 и их применение
|
EP2427207B1
(de)
|
2009-05-05 |
2017-08-16 |
Amgen, Inc |
Fgf21-mutanten und ihre verwendungen
|
MX2011013903A
(es)
*
|
2009-06-17 |
2012-05-08 |
Amgen Inc |
Polipeptidos quimericos y usos de los mismos.
|
BR112012003077A2
(pt)
|
2009-08-14 |
2019-09-24 |
Genentech Inc |
mercadorias biologicas para monitorar resposta em paciente para antagonistas de vegf
|
AU2010289400B2
(en)
|
2009-09-02 |
2014-10-23 |
Curis, Inc. |
Mutant smoothened and methods of using the same
|
US20110064670A1
(en)
|
2009-09-11 |
2011-03-17 |
Genentech, Inc. |
Method to identify a patient with an increased likelihood of responding to an anti-cancer agent
|
US20110111008A1
(en)
*
|
2009-10-08 |
2011-05-12 |
Weng Tao |
Use of PEDF in an Encapsulated Cell-Based Delivery System
|
CA2778442A1
(en)
|
2009-10-22 |
2011-04-28 |
Genentech, Inc. |
Methods and compositions for modulating hepsin activation of macrophage-stimulating protein
|
MX2012005864A
(es)
|
2009-11-20 |
2012-08-31 |
Amgen Inc |
Proteinas de enlace al antígeno anti-orai 1 y usos de las mismas.
|
CN102741294A
(zh)
|
2009-11-30 |
2012-10-17 |
霍夫曼-拉罗奇有限公司 |
治疗和诊断表达slc34a2(tat211=seqid2)的肿瘤的抗体
|
MX2012006397A
(es)
*
|
2009-12-02 |
2012-11-30 |
Amgen Inc |
PROTEINAS DE ENLACE QUE ENLAZAN A FGFR1C HUMANO, ß-KLOTHO HUMANA Y TANTO FGFR1C HUMANO COMO ß-KLOTHO HUMANA.
|
UA109888C2
(uk)
|
2009-12-07 |
2015-10-26 |
|
ІЗОЛЬОВАНЕ АНТИТІЛО АБО ЙОГО ФРАГМЕНТ, ЩО ЗВ'ЯЗУЄТЬСЯ З β-КЛОТО, РЕЦЕПТОРАМИ FGF І ЇХНІМИ КОМПЛЕКСАМИ
|
WO2011075185A1
(en)
|
2009-12-18 |
2011-06-23 |
Oligasis |
Targeted drug phosphorylcholine polymer conjugates
|
MX2012007379A
(es)
|
2009-12-23 |
2012-08-31 |
Genentech Inc |
Anticuerpos anti-bv8 y usos de los mismos.
|
PE20130214A1
(es)
|
2010-02-23 |
2013-03-11 |
Genentech Inc |
Composiciones y metodos para el diagnostico y tratamiento de tumores
|
US9517264B2
(en)
|
2010-04-15 |
2016-12-13 |
Amgen Inc. |
Human FGF receptor and β-Klotho binding proteins
|
PT2561078T
(pt)
|
2010-04-23 |
2018-12-03 |
Cold Spring Harbor Laboratory |
Sharn com uma conceção estrutural inovadora
|
MX342239B
(es)
|
2010-05-03 |
2016-09-21 |
Genentech Inc * |
Composiciones y metodos para el diagnostico y tratamiento de tumores.
|
KR101859124B1
(ko)
|
2010-05-03 |
2018-05-21 |
더 텍사스 에이 & 엠 유니버시티 시스템 |
눈 손상 및 질환 치료용 성체 줄기 세포/전구 세포 및 줄기 세포 단백질
|
WO2011146568A1
(en)
|
2010-05-19 |
2011-11-24 |
Genentech, Inc. |
Predicting response to a her inhibitor
|
EP2596361A1
(de)
|
2010-07-19 |
2013-05-29 |
F.Hoffmann-La Roche Ag |
Verfahren zur identifizierung eines patienten mit erhöhter wahrscheinlichkeit des ansprechens auf eine antitumortherapie
|
JP2013538338A
(ja)
|
2010-07-19 |
2013-10-10 |
エフ・ホフマン−ラ・ロシュ・アクチェンゲゼルシャフト |
抗癌治療への応答可能性の増大した患者を同定する方法
|
EP2725034B1
(de)
|
2010-09-22 |
2019-04-03 |
Amgen Inc. |
Trägerimmunglobuline die nicht an humane Gewebe binden und Verwendungen davon
|
EP2621514B1
(de)
|
2010-09-28 |
2016-09-21 |
KAHR Medical (2005) Ltd |
Zusammensetzungen und verfahren zur behandlung von hämatologischen malignomen
|
EP2446898A1
(de)
|
2010-09-30 |
2012-05-02 |
Laboratorios Del. Dr. Esteve, S.A. |
Verwendung von Wachstumshormonen zur Verbesserung der Immunantwort bei immunsupprimierten Patienten
|
CN108079279B
(zh)
|
2010-10-01 |
2022-04-12 |
霍巴治疗公司 |
镍纹蛋白用于治疗异常性疼痛、痛觉过敏、自发性疼痛和幻痛的用途
|
WO2012047968A2
(en)
|
2010-10-05 |
2012-04-12 |
Genentech, Inc. |
Mutant smoothened and methods of using the same
|
TWI595004B
(zh)
|
2010-11-03 |
2017-08-11 |
介控生化科技公司 |
經修飾之第九因子多胜肽及其用途
|
AU2011336592A1
(en)
|
2010-12-02 |
2013-07-11 |
Neurotech Usa, Inc. |
Cell lines that secrete anti-angiogenic antibody-scaffolds and soluble receptors and uses thereof
|
WO2012088254A1
(en)
|
2010-12-22 |
2012-06-28 |
Genentech, Inc. |
Autophagy inducer and inhibitor combination therapy for the treatment of neoplasms
|
KR101242656B1
(ko)
*
|
2011-03-04 |
2013-03-20 |
포항공과대학교 산학협력단 |
인공 췌도 구조물 및 이의 제조 방법
|
JP2014513948A
(ja)
|
2011-04-20 |
2014-06-19 |
ザ ユニバーシティ オブ ワシントン スルー イッツ センター フォー コマーシャライゼーション |
β2ミクログロブリン欠損細胞
|
US9474786B2
(en)
|
2011-09-05 |
2016-10-25 |
Nsgene A/S |
Treatment of allodynia
|
US20150119399A1
(en)
|
2012-01-10 |
2015-04-30 |
President And Fellows Of Harvard College |
Beta-cell replication promoting compounds and methods of their use
|
BR112014017320A2
(pt)
|
2012-01-13 |
2018-05-29 |
Genentech Inc |
método para determinar se um paciente é propenso a responder ao tratamento com um antagonista de vegf, método para otimizar a eficácia terapêutica de um antagonista de vegf, método para selecionar uma terapia, método para identificar um biomarcador e método para diagnosticar um distúrbio angiogênico
|
EP2634307B1
(de)
|
2012-03-02 |
2016-05-11 |
Valmet Technologies, Inc. |
Verfahren zur Modernisierung eines Superkalenders und eines modernisierten Superkalenders
|
US20130259867A1
(en)
|
2012-03-27 |
2013-10-03 |
Genentech, Inc. |
Diagnosis and treatments relating to her3 inhibitors
|
MX2014011582A
(es)
|
2012-03-30 |
2014-11-21 |
Genentech Inc |
Metodos y composiciones de diagnostico para el tratamiento de cancer.
|
ES2959382T3
(es)
|
2012-04-17 |
2024-02-26 |
Univ Washington Through Its Center For Commercialization |
Células deficientes en HLA de clase II y células deficientes en HLA de clase I capaces de expresar proteínas HLA de clase II, y usos de las mismas
|
CN104640579A
(zh)
|
2012-05-30 |
2015-05-20 |
神经技术美国有限公司 |
冷冻保存的可植入细胞培养装置及其用途
|
CA2879785C
(en)
|
2012-07-25 |
2019-06-18 |
Catalyst Biosciences, Inc. |
Modified factor x polypeptides and uses thereof
|
US9458246B2
(en)
|
2013-03-13 |
2016-10-04 |
Amgen Inc. |
Proteins specific for BAFF and B7RP1
|
JOP20140087B1
(ar)
|
2013-03-13 |
2021-08-17 |
Amgen Inc |
بروتينات مخصصة ل baff و b7rp1 وإستخداماتها
|
US20140283157A1
(en)
|
2013-03-15 |
2014-09-18 |
Diadexus, Inc. |
Lipoprotein-associated phospholipase a2 antibody compositions and methods of use
|
WO2014173441A1
(en)
*
|
2013-04-24 |
2014-10-30 |
Nestec S.A. |
Encapsulation device
|
US9907496B1
(en)
|
2013-06-25 |
2018-03-06 |
National Technology & Engineering Solutions Of Sandia, Llc |
Optoelectronic system and apparatus for connection to biological systems
|
US10456470B2
(en)
|
2013-08-30 |
2019-10-29 |
Genentech, Inc. |
Diagnostic methods and compositions for treatment of glioblastoma
|
US10617755B2
(en)
|
2013-08-30 |
2020-04-14 |
Genentech, Inc. |
Combination therapy for the treatment of glioblastoma
|
PL3041513T3
(pl)
|
2013-09-08 |
2021-01-25 |
Kodiak Sciences Inc. |
Obojnaczojonowe polimerowe koniugaty czynnika viii
|
WO2015038669A1
(en)
|
2013-09-11 |
2015-03-19 |
Neurotech Usa, Inc. |
Encapsulated cell therapy cartridge
|
WO2015116902A1
(en)
|
2014-01-31 |
2015-08-06 |
Genentech, Inc. |
G-protein coupled receptors in hedgehog signaling
|
JP6736467B2
(ja)
|
2014-02-04 |
2020-08-05 |
ジェネンテック, インコーポレイテッド |
平滑化変異体及びその使用方法
|
MA39817A
(fr)
|
2014-03-31 |
2017-02-08 |
Hoffmann La Roche |
Thérapie combinatoires comprenant des agents anti-angiogenèse et des agonistes se liant à ox40
|
US9840553B2
(en)
|
2014-06-28 |
2017-12-12 |
Kodiak Sciences Inc. |
Dual PDGF/VEGF antagonists
|
EP3169801A1
(de)
|
2014-07-14 |
2017-05-24 |
F. Hoffmann-La Roche AG |
Diagnostische verfahren und zusammensetzungen zur behandlung von glioblastomen
|
US9764122B2
(en)
|
2014-07-25 |
2017-09-19 |
Warsaw Orthopedic, Inc. |
Drug delivery device and methods having an occluding member
|
US9775978B2
(en)
|
2014-07-25 |
2017-10-03 |
Warsaw Orthopedic, Inc. |
Drug delivery device and methods having a retaining member
|
WO2016061141A1
(en)
|
2014-10-13 |
2016-04-21 |
University Of Maryland, Baltimore |
Methods for treating cardiovascular dysfunction and improving fluid homeostasis with a peptide hormone
|
EP3207128B1
(de)
|
2014-10-17 |
2022-07-27 |
Kodiak Sciences Inc. |
Zwitterionische butyrylcholinesterasepolymerkonjugate
|
WO2016106340A2
(en)
|
2014-12-23 |
2016-06-30 |
Genentech, Inc. |
Compositions and methods for treating and diagnosing chemotherapy-resistant cancers
|
CN107223163A
(zh)
|
2014-12-24 |
2017-09-29 |
豪夫迈·罗氏有限公司 |
用于膀胱癌症的治疗,诊断和预后方法
|
EP3240908A2
(de)
|
2014-12-30 |
2017-11-08 |
F. Hoffmann-La Roche AG |
Verfahren und zusammensetzungen zur diagnose und behandlung von krebs
|
CA2975875A1
(en)
|
2015-02-04 |
2016-08-11 |
Genentech, Inc. |
Mutant smoothened and methods of using the same
|
US10456356B2
(en)
|
2015-05-27 |
2019-10-29 |
Neurotech Usa, Inc. |
Use of encapsulated cell therapy for treatment of ophthalmic disorders
|
US20170000885A1
(en)
|
2015-06-08 |
2017-01-05 |
Genentech, Inc. |
Methods of treating cancer using anti-ox40 antibodies and pd-1 axis binding antagonists
|
HRP20220304T1
(hr)
|
2015-06-24 |
2022-05-13 |
F. Hoffmann - La Roche Ag |
Anti-transferinska receptorska protutijela s prilagođenim afinitetom
|
EP3356406A1
(de)
|
2015-10-02 |
2018-08-08 |
H. Hoffnabb-La Roche Ag |
Bispezifische antikörper gegen menschliches cd20/gegen den menschlichen transferrinrezeptor und verfahren zur verwendung
|
AR106189A1
(es)
|
2015-10-02 |
2017-12-20 |
Hoffmann La Roche |
ANTICUERPOS BIESPECÍFICOS CONTRA EL A-b HUMANO Y EL RECEPTOR DE TRANSFERRINA HUMANO Y MÉTODOS DE USO
|
EP3359572A2
(de)
|
2015-10-06 |
2018-08-15 |
H. Hoffnabb-La Roche Ag |
Verfahren zur behandlung von multipler sklerose
|
US10076650B2
(en)
|
2015-11-23 |
2018-09-18 |
Warsaw Orthopedic, Inc. |
Enhanced stylet for drug depot injector
|
RU2744860C2
(ru)
|
2015-12-30 |
2021-03-16 |
Кодиак Сайенсиз Инк. |
Антитела и их конъюгаты
|
WO2017136558A1
(en)
|
2016-02-04 |
2017-08-10 |
Curis, Inc. |
Mutant smoothened and methods of using the same
|
AU2017268234A1
(en)
|
2016-05-17 |
2018-12-13 |
Genentech, Inc. |
Stromal gene signatures for diagnosis and use in immunotherapy
|
US10183058B2
(en)
|
2016-06-17 |
2019-01-22 |
Nymox Corporation |
Method of preventing or reducing the progression of prostate cancer
|
USD802755S1
(en)
|
2016-06-23 |
2017-11-14 |
Warsaw Orthopedic, Inc. |
Drug pellet cartridge
|
KR20190022563A
(ko)
*
|
2016-06-28 |
2019-03-06 |
고쿠리츠겐큐가이하츠호징 노우교 · 쇼쿠힝 산교기쥬츠 소고겐큐기코 |
세포 봉입용 디바이스 및 그 사용
|
US10172910B2
(en)
|
2016-07-28 |
2019-01-08 |
Nymox Corporation |
Method of preventing or reducing the incidence of acute urinary retention
|
US10532081B2
(en)
|
2016-09-07 |
2020-01-14 |
Nymox Corporation |
Method of ameliorating or preventing the worsening or the progression of symptoms of BPH
|
US10434261B2
(en)
|
2016-11-08 |
2019-10-08 |
Warsaw Orthopedic, Inc. |
Drug pellet delivery system and method
|
WO2018152496A1
(en)
|
2017-02-17 |
2018-08-23 |
The Usa, As Represented By The Secretary, Dept. Of Health And Human Services |
Compositions and methods for the diagnosis and treatment of zika virus infection
|
CA3059938A1
(en)
|
2017-04-14 |
2018-10-18 |
Kodiak Sciences Inc. |
Complement factor d antagonist antibodies and conjugates thereof
|
EP4230649A3
(de)
|
2017-04-25 |
2023-10-25 |
The U.S.A. As Represented By The Secretary, Department Of Health And Human Services |
Antikörper und verfahren zur diagnose und behandlung von epstein barr-virusinfektion
|
BR112019027583A2
(pt)
|
2017-06-22 |
2020-10-06 |
Catalyst Biosciences, Inc. |
polipeptídeos de serina protease 1 tipo membrana (mtsp-1) modificados e métodos de uso
|
CN111094334A
(zh)
|
2017-07-19 |
2020-05-01 |
美国卫生与公众服务部 |
用于诊断和治疗乙肝病毒感染的抗体和方法
|
US11951206B2
(en)
|
2017-09-29 |
2024-04-09 |
Vertex Pharmaceuticals Incorporated |
Cell housing device
|
US20210171610A1
(en)
|
2018-05-02 |
2021-06-10 |
The U.S.A., As Represented By The Secretary, Department Of Health And Human Services |
Antibodies and methods for the diagnosis, prevention, and treatment of epstein barr virus infection
|
CA3100200A1
(en)
|
2018-05-21 |
2019-11-28 |
Nanostring Technologies, Inc. |
Molecular gene signatures and methods of using same
|
WO2019235581A1
(ja)
|
2018-06-06 |
2019-12-12 |
国立大学法人大阪大学 |
Regnase-1が関与する疾患の治療および/または予防方法
|
DE102018006061A1
(de)
*
|
2018-08-01 |
2020-02-06 |
Universität Duisburg-Essen |
Implantat
|
WO2020140101A1
(en)
|
2018-12-28 |
2020-07-02 |
Catalyst Biosciences, Inc. |
Modified urokinase-type plasminogen activator polypeptides and methods of use
|
US11613744B2
(en)
|
2018-12-28 |
2023-03-28 |
Vertex Pharmaceuticals Incorporated |
Modified urokinase-type plasminogen activator polypeptides and methods of use
|
EP3947441A1
(de)
|
2019-03-27 |
2022-02-09 |
UMC Utrecht Holding B.V. |
Manipulierte iga-antikörper und verfahren zur verwendung
|
EP3833381B1
(de)
|
2019-08-15 |
2022-08-03 |
Catalyst Biosciences, Inc. |
Modifizierte faktor-vii-polypeptide zur subkutanen verabreichung
|
CA3157509A1
(en)
|
2019-10-10 |
2021-04-15 |
Kodiak Sciences Inc. |
Methods of treating an eye disorder
|
EP4051192A1
(de)
*
|
2019-11-01 |
2022-09-07 |
Neurotech USA, Inc. |
System, geräte, vorrichtungen und verfahren für eine implantierbare analyse-diffusionsvorrichtung
|
WO2022011081A1
(en)
|
2020-07-09 |
2022-01-13 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Cell lines that produce human retinoschisin proteins and uses thereof
|
CN115591025B
(zh)
*
|
2022-11-09 |
2024-01-02 |
深圳先进技术研究院 |
神经调控器件、制备方法及其应用
|